Conferences and Meetings on Pharmacology and Drug Development

Select a location
iPharma Expo 2022, USA — International Pharmaceutical Business Expo 2022
26 May 2022 - 27 May 2022 • Boston,USA, United States
iPharma Expo 2022, USA (International Pharmaceutical Business Expo 2022) scheduled during May 26- 27, 2022, at Boston, U.S.A. This expo will showcase the latest trends and technologies in pharmaceuticals, drugs and formulations and will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries. iPharma Expo 2022 is expected to witness approx. 150 exhibitor’s and 1500- 2000 visitors footfall from pharma industry, management etc. bringing unique platform for the participating companies to display their products & services to the gamut of visitors, globally from pharma and healthcare industries.
Phone: [6193784851];     Email:
Phrarmacology, Pharma Manufacturing, Pharma Market
Event listing ID:
Medicinal Chemistry Residential School 2022
05 Jun 2022 - 10 Jun 2022 • Loughborough, United Kingdom
The Royal Society of Chemistry
The school is designed for graduate and post-doctoral chemists with 1-5 years’ experience in the field of drug research. Drug discovery is an interdisciplinary subject so delegates from biological or computational backgrounds will benefit from attendance at the school. In addition, final year PhD students from pharmaceutical or organic chemistry contemplating a career in drug discovery are also encouraged to attend.
The Royal Society of Chemistry Medicinal Chemistry Residential School will cover topics of interest to drug discovery researchers, helping to increase understanding of the factors governing modern drug discovery from the initial concept through to translational science and intellectual property. Established since 1981, our Residential School has trained many of the world’s leading medicinal chemists working in the pharmaceutical industry and academic research institute.
Abstract submission deadline:
09 May 2022
Event listing ID:
What's new in immunotherapies 2022
07 Jun 2022 • London, United Kingdom
SCI (Society of Chemical Industry)
Immunotherapy is a hot-topic field of research that has generated significant scientific interest and fuelled industrial innovation. It has been demonstrated that small, drug-like molecules can be highly effective modulators of immune response pathways and that their molecular properties can be fine-tuned to enable excellent cell permeability and bioavailability. This makes them ideal for use in the treatment of chronic conditions such as autoimmune and inflammation-related diseases. Excitingly, this approach also offers the possibility to treat cancer by harnessing the body’s own immune system to fight tumours. This meeting will offer a broad introduction to those new to the topic and showcase recent innovations by academic and industrial scientists in this exciting and rapidly expanding field.
Conferences Team;     Phone: [+44 (0)20 7598 1561];     Email:
immunotherapy, drug discovery, immuno-oncology cellular immunology, molecular immunology, novel drug delivery systems, cancer immunotherapy, small molecule inhibitors, drug discovery and development obstacles, cell immunotherapy, immunology
Event listing ID:
Related subject(s):
Gordon Research Seminar — Drug Safety
18 Jun 2022 - 19 Jun 2022 • Stonehill College, Easton, United States
Event listing ID:
Gordon Research Conference — Drug Safety
19 Jun 2022 - 24 Jun 2022 • Stonehill College, Easton, United States
Event listing ID:
SMi’s 5th Pharmaceutical Microbiology West Coast Conference
20 Jun 2022 - 22 Jun 2022 • San Diego, California, United States
SMi Group
Microbiology remains an essential tool for the detection of microorganisms to protect patients globally. The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revised industry regulation, enhanced knowledge of innovative therapies, and novel testing methods, this industry is ever expanding. This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and minimisation of operator intervention, to the latest technologies in rapid microbiological testing methods and data integrity.
Phone: [+44 (0) 20 7827 6162];     Email:
Pharmaceutical, microbiology, contamination, microbial, biofilms, sterility, quality assurance, mycoplasma, data integrity, microbiome, Endotoxin Pharmaceutical Microbiology, Contamination, Pharmaceuticals, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control, Rapid Microbial Methods, Data Integrity, Risk Assessments, Environmental Monitoring, Microbiologist, Biofilms,
Event listing ID:
Gordon Research Seminar — Drug Resistance
25 Jun 2022 - 26 Jun 2022 • Bryant University, Smithfield, United States
Event listing ID:
Gordon Research Seminar — Personalized Medicine
25 Jun 2022 - 26 Jun 2022 • Ventura, United States
37th ACS National Medicinal Chemistry Symposium
26 Jun 2022 - 29 Jun 2022 • New York, United States
American Chemical Society (ACS) Division of Medicinal Chemistry
The Division of Medicinal Chemistry of the ACS organizes its National Medicinal Chemistry Symposium in even-numbered years since 1948.
Event listing ID:
Event website:
Gordon Research Conference — Drug Resistance
26 Jun 2022 - 01 Jul 2022 • Bryant University, Smithfield, United States
Event listing ID:
Gordon Research Conference — Personalized Medicine
26 Jun 2022 - 01 Jul 2022 • Ventura, United States
Event listing ID:
22nd Tetrahedron Symposium — Catalysis for a Sustainable World
28 Jun 2022 - 01 Jul 2022 • Lisbon, Portugal
The annual Tetrahedron Symposium is the premier conference in organic, bio-organic and medicinal chemistry. Join us in Lisbon for a topical programme which will bring together an expert line-up of invited speakers to communicate and share their latest results.
Abstract submission deadline:
18 Feb 2022
Event listing ID:
Gordon Research Seminar — Drug Metabolism
09 Jul 2022 - 10 Jul 2022 • Holderness School, Holderness, United States
Event listing ID:
Related subject(s):
Gordon Research Conference — Drug Metabolism
10 Jul 2022 - 15 Jul 2022 • Holderness School, Holderness, United States
Event listing ID:
Related subject(s):
Gordon Research Seminar — Drug Carriers in Medicine and Biology
30 Jul 2022 - 31 Jul 2022 • Mount Snow, West Dover, United States
Gordon Research Conference — Drug Carriers in Medicine and Biology
31 Jul 2022 - 05 Aug 2022 • Mount Snow, West Dover, United States
GP2A 30th Annual Conference
24 Aug 2022 - 26 Aug 2022 • Dublin , Ireland
Group for the Promotion of Pharmaceutical chemistry in Academia (GP2A)
The Group for the Promotion of Pharmaceutical chemistry in Academia (GP2A) is a member-led network of academic medicinal chemists working in universities and research institutes in Europe.Founded in 1992, as the Groupement des Pharmacochimistes de l’Arc Atlantique (GP2A) by medicinal chemists working within Schools of Pharmacy near the western coast of Europe (the “Atlantic Arc”), it has rapidly expanded and currently includes academic members from France, Spain, Germany, Portugal, Ireland and the United Kingdom.
Abstract submission deadline:
03 Jun 2022
Event listing ID:
EFMC-ISMC 2022 — XXVII EFMC International Symposium on Medicinal Chemistry
04 Sep 2022 - 08 Sep 2022 • Nice, France
The XXVll EFMC International Symposium on Medicinal Chemistry is organised by the Société de Chimie Thérapeutique (SCT), on behalf of the European Federation for Medicinal Chemistry and Chemical Biology (EFMC).
The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 26 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts around 1.000 participants both from industry and academia. The most recent EFMC-ISMC meeting took place in tSlovenia (Ljubljana, 2018), while the edition initially planned for Basel, Switzerland in 2020 has been run as a Virtual Event in 2021.

The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer. EFMC-ISMC 2022 will also feature most recent advances in new technologies such as the exploitation of RNA as drug target, artificial intelligence in drug discovery, natural products-based drug discovery, DNA encoded libraries applications and the development of covalent drugs, PROTACs and molecular glues. Innovative approaches in medicinal chemistry will be included such as the development of immunomodulating compounds or the application of affinity selection – mass spectrometry for drug discovery. In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such as in vivo chemistry for target discovery and validation, molecular imaging, and photochemical approaches. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.

Abstract submission deadline:
24 Mar 2022
Event listing ID:
IC2AR 2022 — 5th International Caparica Conference in Antibiotic Resistance 2022
05 Sep 2022 - 08 Sep 2022 • Caparica, Portugal
In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary. The use of antibiotics constitutes an important factor for the selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility of therapeutic failure. The appearance of multiresistant bacteria is probably accompanied by co-contamination of the environment, leading to a major clinical and public health concern within the lifetime of most people living today. The extensive use has heightened concerns about the expression of antimicrobial resistance, which impacts human and animal safety, food safety and environmental exposure. Antibiotic resistance is an emergent problem, and for this reason, the WHO appealed for an urgent and concerted action by governments, health professionals, industry, civil society and patients to slow down the spread of drug resistance, limit its impact today and preserve medical advances for future generations. In the latest years, much investigation was developed to understand the emergence of the resistance genes and their spread but this fact does not let us control totally this problem. In this conference, an attempt has been made to present the latest research on possibilities to manage this question.
Abstract submission deadline:
15 Mar 2022
Event listing ID:
Related subject(s):
7th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems
08 Sep 2022 - 10 Sep 2022 • Paris, France
Magnus Groups
We provide a one-of-a-kind and precisely managed agenda that blends the most relevant marketing and sales information. This summit is the eyes and ears of Pharma industry, brimming with inspirational content, the latest marketing and sales trends, and actionable ways to utilize digital opportunities so you can have an overview of the recent trends in the field of Drug delivery and pharmaceutics. Many academicians, researchers, scientists, pharmacists and industry representatives working in these promising fields will attend this conference.
Formulation Technologies Advanced Drug Delivery Systems Pharmacology Preformulation Studies Pharmacovigilance and Drug Safety Biotherapy and Radiopharmaceuticals
Event listing ID:
Oligonucleotide Therapeutics and Delivery Conference 2022
21 Sep 2022 - 22 Sep 2022 • London, United Kingdom
SMi Group
Oligonucleotide Therapeutics and Delivery Conference 2022

Date: 21st – 22nd September 2022

Location: London, UK


Advancements in extra-hepatic delivery of oligonucleotides

The Oligonucleotide Therapeutics and Delivery conference reveals the latest in oligonucleotide discovery and delivery, with presentations on targeted delivery mechanisms, oligonucleotide chemistries and important clinical advances. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of oligonucleotides with case studies surrounding the discovery and development of oligonucleotide therapeutics as well as CMC and regulatory standpoints. The two-day conference will bring you high-quality insights and industry connections on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY.

Established on the success of our RNA Therapeutics series, we look forward to welcoming you at Oligonucleotide Therapeutics and Delivery to join the conversation around maximizing the potential of oligo-based treatments.

Benefits of attending:

•Listen to case studies presenting on pre-clinical and clinical research in areas such as oncology and what can be learned for future clinical trials

•Deepen your understanding of oligonucleotide therapeutic delivery and explore the latest innovations in extrahepatic oligonucleotide delivery and target specificity

• Understand the regulatory and CMC environment surrounding oligonucleotide therapeutic development

•Explore developments in oligonucleotide chemistries and examine developments in novel applications of antisense oligonucleotides and siRNA

•Engage in the latest innovations in oligonucleotide therapeutics such as utilising AI machine learning to drive the discovery of novel therapeutics

Plus, two interactive half day pre-conference workshops on 20th September 2022:

•Oligonucleotide Therapies- Overcoming The Challenges Of Delivery led by Nick Lench, Executive Director, NATA, Martin Kerr, Head of Business Development & Partnerships, Nucleic Acid Therapy Accelerator, Ritwick Sawakar, MRC Investigator, MRC Toxicology Unit, University Of Cambridge

•Managing CMC Activities For The Development Of Oligonucleotide Therapeutics led by Mia Kiistala, CEO/Owner/Principal Consultant, Aurora CMC Consulting


•Ekkehard Leberer, Senior Life Sciences Consultant, Elbicon

•Jimmy Weterings, Principal Scientist, AstraZeneca


•Shalini Anderson, Vice President Oligonucleotide Discovery,AstraZeneca

•Heinrich Haas, Vice President RNA Formulation & Drug Delivery, BioNTech

•Tamar Grossman, Global Head of RNA and Targeted Therapeutics, Janssen pharmaceuticals

•Sarah Tabrizi,Director of UCL Huntington’s disease centre, UCL Institute of Neurology

•Macarena Hernandez-Jimenez, Chief Scientific Officer, AptaTargets

•David Evans, Chief Scientific Officer, Sirnaomics

•Eric Lim, Director, Platform, Discover Research, Stoke Therapeutics, Inc.

•Chris Chorley, Associate Director, Global Regulatory CMC, Biogen

•Oliver Ernst, Managing Director, Chief Operating Officer, Neuway Pharma GmbH

Nick Lench, Executive Director, Nucleic Acid Therapy Accelerator

Bart Anderson, Senior Director of R&D, Exicure

Who should attend:

Executives, Directors, VPs, Heads, Principals, Managers of:

-RNA Biology/Discovery

-Novel Therapeutic Modalities

-Innovation Technologies

-C-level Scientific Executives

-Formulation and Drug Delivery

-Clinical Research and Development

-Cell Biology



Additional Contact Info:

T: +44 (0)2 £200 0 7827 6154


LinkedIn: SMi Pharma

Twitter: @SMiPharma | #SMiOligonucleotides

Phone: [+44 (0) 20 7827 6154];     Email:
Small interfering RNA, siRNA, Antisense therapy, DNA, RNA, nucleic acid, mRNA, Micro RNA, RNA-induced silencing complex, RISC, Aptamers, oligonucleotide, peptide molecules, Immunogenicity, Drug pipeline, short interfering RNA, silencing RNA, RNA interference, RNAi, mRNA degradation
Event listing ID:
Related subject(s):
Equipment Validation, Tracking, Calibration and Preventive Maintenance
23 Sep 2022 • online, United States

FDA and EU regulations require that firms have a program for the calibration and maintenance of test and measurement equipment.

The program must include: intervals, scheduling, specific procedures, limits of accuracy/precision, and remedial action in the event that the equipment does not meet established requirements.

Compliance4all;     Phone: [8004479407];     Email:
Event listing ID:
Related subject(s):
Training — Chemical Development & Scale-Up in the Fine Chemical & Pharmaceutical Industries
17 Oct 2022 - 19 Oct 2022 • San Francisco, United States
EMBO Lecture Course — Microphysiological systems: Advances and applications in human-relevant research
31 Oct 2022 - 05 Nov 2022 • Hyderabad, India
European Molecular Biology Organization – EMBO
There has been an increasing awareness in the scientific community regarding the inability of animal models to often capture the complexities of human biology. In the last decade, there have been significant advances in the field of model systems that are based on human biology, including microphysiological systems (MPS). These systems aim to recapitulate the physiology and functions of a single human organ or a network of organs at a smaller scale, such as organoids or organs-on-chip. MPS have often been proposed as the next frontier of human-relevant research in drug discovery and testing. The lecture course will give an overview of the current research of how these model systems are being used to understand human disease and development. It will also cover design considerations, current challenges, setting standards and roadmap for broader adoption and use of these systems. In addition, the course would have networking sessions for early career researchers and students, along with discussions on collaborations, international grants, and entrepreneurship.
Abstract submission deadline:
10 Aug 2022
Event listing ID:
Related subject(s):
Training — Molecule to Medicine
01 Nov 2022 - 03 Nov 2022 • Oxford, United Kingdom
Training — Understanding Polymorphism & Crystallisation Issues in the Pharmaceutical Industry
09 Nov 2022 - 11 Nov 2022 • Milan, Italy
Training — Quality by Design in Pharmaceutical Development
28 Nov 2022 - 02 Dec 2022 • Online Platform, Any Location (virtual event)
OMP 2023 — Optical Molecular Probes, Imaging and Drug Delivery
24 Apr 2023 - 27 Apr 2023 • Vancouver, BC, Canada
Focuses on the convergence in these rapidly evolving areas, spanning from basic biology to clinical diagnostics and therapeutic applications. This multidisciplinary topical meeting will highlight recent advances in these rapidly evolving areas with a goal of stimulating novel strategies for molecular probe development, site-specific drug delivery, monitoring treatment response and clinical translation to improve diagnosis or treatment of diseases. Areas to be covered include, but are not limited to, novel molecular probe design, applications of smart molecular probes in basic and applied research, endogenous and exogenous optical molecular biomarkers, multimodal imaging, advances in instrumentation and algorithms for optical molecular imaging, molecular and functional imaging of normal and diseased tissue, image-guided drug delivery, drug screening and monitoring therapeutic response.
Event listing ID:
1468469 offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

No tracking | No pop-ups | No animations
Last updated: 18 April 2022